Free Trial

Hypermarcas (OTCMKTS:HYPMY) Sees Large Volume Increase - Here's What Happened

Hypermarcas logo with Medical background

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) shares saw an uptick in trading volume on Wednesday . 429,810 shares traded hands during mid-day trading, an increase of 3,045% from the previous session's volume of 13,666 shares.The stock last traded at $5.07 and had previously closed at $5.02.

Hypermarcas Stock Performance

The stock's 50 day simple moving average is $4.20 and its two-hundred day simple moving average is $3.56. The company has a market capitalization of $3.08 billion, a P/E ratio of 20.23 and a beta of 0.79. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.26 and a quick ratio of 0.80.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The company reported ($0.04) earnings per share for the quarter. Hypermarcas had a net margin of 12.51% and a return on equity of 6.95%. The company had revenue of $184.34 million during the quarter.

Hypermarcas Company Profile

(Get Free Report)

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.

Read More

Should You Invest $1,000 in Hypermarcas Right Now?

Before you consider Hypermarcas, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hypermarcas wasn't on the list.

While Hypermarcas currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines